Antalarmin structure
|
Common Name | Antalarmin | ||
---|---|---|---|---|
CAS Number | 157284-96-3 | Molecular Weight | 378.55400 | |
Density | 1.05g/cm3 | Boiling Point | 437.2ºC at 760mmHg | |
Molecular Formula | C24H34N4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 218.2ºC |
Use of AntalarminAntalarmin is a selective nonpeptide corticotropin-releasing factor receptor 1 (CRHR1) antagonist with a Ki of 2.7 nM. Antalarmin can pass through the blood–brain barrier[1][2][3]. |
Name | N-butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-amine |
---|---|
Synonym | More Synonyms |
Description | Antalarmin is a selective nonpeptide corticotropin-releasing factor receptor 1 (CRHR1) antagonist with a Ki of 2.7 nM. Antalarmin can pass through the blood–brain barrier[1][2][3]. |
---|---|
Related Catalog | |
Target |
Ki: 2.7 nM (CRHR1)[3] |
In Vitro | Antalarmin 通过 cAMP/PKA 信号通路抑制促肾上腺皮质激素释放因子 (CRF) 对 Aβ1-42 水平的影响[2]。 Western Blot Analysis[2] Cell Line: Primary hippocampal neurons derived from Tg2576 mice Concentration: 100 nM Incubation Time: 48 h Result: Blocked CRF-induced increases in PKAIIβ levels. |
In Vivo | Antalarmin (10 mg/kg; i.p.; daily for 4 weeks) 可以改善小鼠的慢性轻度应激 (CMS) 诱导的变化[1]。 Antalarmin (20 mg/kg; i.p.; daily for 7 days) 显著降低亚急性应激 Tg2576 小鼠中 Aβ1-42 水平[2]。 Animal Model: BALB/cByJIco male mice, chronic mild stress model[1] Dosage: 10 mg/kg Administration: Intraperitoneal injection, daily for 4 weeks Result: Induced a significant improvement of mice physical state. Induced a nonsignificant decrease of the lit box (TLB) and activity when compared to controls. |
References |
Density | 1.05g/cm3 |
---|---|
Boiling Point | 437.2ºC at 760mmHg |
Molecular Formula | C24H34N4 |
Molecular Weight | 378.55400 |
Flash Point | 218.2ºC |
Exact Mass | 378.27800 |
PSA | 33.95000 |
LogP | 5.89730 |
Vapour Pressure | 7.63E-08mmHg at 25°C |
Index of Refraction | 1.574 |
7H-Pyrrolo(2,3-d)pyrimidin-4-amine,N-butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl) |
Antalarmin |